|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| C07K 17/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| A61K 48/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 2500030 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12172001.5 |
| Date of filing the European patent application | 2006-11-04 | |
| (97) | Date of publication of the European application | 2012-09-19 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-22 |
| (46) | Date of publication of the claims translation | 2015-10-26 |
| (30) | Number | Date | Country code |
| 733763 P | 2005-11-04 | US |
| (72) |
Fung, Sek Chung, US
Yao, Zhengbin, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Į komplementą nukreiptų inhibitorių panaudojimas akių ligų gydymui |
| Use of complement pathway inhibitors to treat ocular diseases |
| Payment date | Validity (years) | Amount | |
| 2018-11-02 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-11-04 |